Considering how patients from different ethnic groups respond to the same drug could be crucial to finding new Alzheimer’s disease treatments—a disorder the Alzheimer’s Association previously deemed a “silent epidemic” among Black adults.
Considering how patients from different ethnic groups respond to the same drug could be crucial to finding new Alzheimer’s disease treatments—a disorder the Alzheimer’s Association previously deemed a “silent epidemic” among Black adults.